Literature DB >> 14563576

Percutaneous treatment of saphenous vein graft disease: the ongoing challenge.

Donald S Baim.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14563576     DOI: 10.1016/s0735-1097(03)01039-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  Mechanical and biocompatible characterizations of a readily available multilayer vascular graft.

Authors:  Krishna Madhavan; Winston H Elliott; Walter Bonani; Eric Monnet; Wei Tan
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2012-11-19       Impact factor: 3.368

2.  Percutaneous coronary intervention strategies and prognosis for graft lesions following coronary artery bypass grafting.

Authors:  Yin Liu; Xiujun Zhou; Hua Jiang; Mingdong Gao; Lin Wang; Yutian Shi; Jing Gao
Journal:  Exp Ther Med       Date:  2015-03-16       Impact factor: 2.447

3.  Comparison between the STENTYS self-apposing bare metal and paclitaxel-eluting coronary stents for the treatment of saphenous vein grafts (ADEPT trial).

Authors:  A J J IJsselmuiden; C Simsek; A G van Driel; D Bouchez; G Amoroso; P Vermeersch; P P Karjalainen
Journal:  Neth Heart J       Date:  2018-02       Impact factor: 2.380

4.  Spontaneous recanalization of a completely occluded saphenous vein graft two months following acute myocardial infarction with persistent one year patency.

Authors:  Patrick P Hu; Kirk L Peterson; Sotirios Tsimikas
Journal:  J Thromb Thrombolysis       Date:  2009-07       Impact factor: 2.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.